Latest Breaking News On - தகவல்கள் பாதுகாப்பு கண்காணிப்பு குழு - Page 1 : comparemela.com

Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study

Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United kingdomGus johnsonResponse networkBritish association of stroke physiciansData safety monitoring committeeUnited kingdom research institutesResearch councilUnited kingdom department of healthUnited kingdom medical research council global effortEuropean stroke organizationGlobal health research group on brain infectionsSteering committeeElsevier ltdAssociation of british neurologistsInternational study on cerebral veinStroke association

ReViral to continue Phase II paediatric trial of sisunatovir for RSV

ReViral to continue Phase II paediatric trial of sisunatovir for RSV
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

Hong kongAlex sapirData safety monitoring committeeIndian defence researchDevelopment organisationஹாங் காங்அலெக்ஸ் சபிர்தகவல்கள் பாதுகாப்பு கண்காணிப்பு குழுஇந்தியன் பாதுகாப்பு ஆராய்ச்சிவளர்ச்சி ஆர்கநைஸேஶந்

ReViral Ltd : ReViral Announces Positive Recommendation by the Data Safety Monitoring Committee to Continue the Phase 2 Clinical Study of Sisunatovir for Treatment of Respiratory Syncytial Virus Infections in Hospitalized Infants

ReViral Ltd : ReViral Announces Positive Recommendation by the Data Safety Monitoring Committee to Continue the Phase 2 Clinical Study of Sisunatovir for Treatment of Respiratory Syncytial Virus Infections in Hospitalized Infants
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Hong kongEddy littlerAlan mussoKostenloser wertpapierhandelAlexc sapirNational institute of healthData safety monitoring committeeDrug administrationReviral ltdSafety monitoring committeeChief operatingFast trackRespiratory syncytial virusBased national instituteஹாங் காங்ஆலன் மூஸொ

Pharmaceuticals

Pharmaceuticals
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesLincoln parkJohn vandermostenBrooklyn immunotherapeuticsCaladrius biosciencesData safety monitoring committeeVascular biogenics ltdGainers anchiano therapeutics ltdSystems incGainers second sight medical products incGainers vertex energy incLincoln park capital fundChina liberal education holdings limitedExpresspa groupGainers morphic holding incXpresspa group inc

Cardiol Therapeutics Inc is commercializing its THC-free cannabidiol formulation to treat heart disease

Proprietary formulation produces ultra-pure pharmaceutical cannabidiol (CBD) without the psychotropic effects of THC for the treatment of inflammatory heart disease Received US FDA approval to commence a Phase II/III COVID-19 trial investigating the cardioprotective properties of CardiolRx Has launched Cortalex through a national agreement with Medical Cannabis by Shoppers to retail it on an exclusive basis across Canada Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF) is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease. The Canadian specialty pharmaceutical company has developed a proprietary formula of ultra-pure pharmaceutical cannabidiol (CBD) that does not contain THC - less than 5 parts per million (ppm) - and consequently none of the psychotropic effects of THC.

United statesDouglas loeLeede jones gableAndrew hamerDavid elsleyCardiometabolic at amgen incData safety monitoring committeeGlobal developmentDalton pharma servicesDrug administrationClinical endpoint committeeToronto stock exchangeCompletion of health canadaMedical cannabisNorth americaExecutive director